🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The Teal Wand will be sold through Teal Health’s website and telehealth platform—starting in June in California, before expanding nationwide. fiercebiotech.com/medtech/fda-ap…

Roche plans to invest as much as $550 million in its Indianapolis diagnostics campus during the next five years, with plans to build it into a U.S. manufacturing and distribution hub for its wearable diabetes blood sugar sensors. fiercebiotech.com/medtech/roche-…

Roche tapped a subsidiary of the MIT and Harvard research center to apply sequencing-by-expansion tech in screening newborns and their parents. fiercebiotech.com/medtech/roche-…

With Illumina currently banned from shipping its DNA sequencers into China—in retaliation for the Trump administration’s on-again, off-again tariffs against the country—rival manufacturer PacBio aims to step into the gap. fiercebiotech.com/medtech/illumi…

Boston Scientific is pulling its latest transcatheter aortic heart valve platform from the worldwide market and said it will no longer pursue an approval in the U.S., following recent stumbles in a clinical study. fiercebiotech.com/medtech/boston…

This week on "The Top Line," the Fierce team breaks down Big Pharma Q1 earnings, discusses gene therapy highlights from the ASGCT conference and shares an ASCO meeting preview. omny.fm/shows/the-top-…

Fierce Medtech's Fierce 15 is live! In medtech, innovation almost always means iteration, but that doesn’t preclude novel breakthroughs. These 15 companies identify unmet needs that were beyond the reach of yesterday’s technologies. fiercebiotech.com/special-report…

Major medtech companies are preparing for significant financial headwinds as tariffs threaten to disrupt the $200 billion U.S. medical device market. fiercebiotech.com/medtech/tariff…

A new study suggests that using the Guardant360 CDx test to spot early signs of therapy resistance in advanced breast cancer patients and inform a treatment change could slash the risk of disease progression or death by half. fiercebiotech.com/medtech/asco-g…

Startup Clairity scored a green light from the FDA for the agency's first artificial intelligence tool designed to predict five-year breast cancer risk from a routine screening mammogram. fiercebiotech.com/medtech/fda-cl…

After raising nearly $170 million in venture capital financing earlier this year—and nearly $2 billion over the past decade—Caris Life Sciences now aims to add about $400 million more to its coffers by going public following 17 years in the business. fiercebiotech.com/medtech/cancer…

Multiple developers of connected diabetes hardware have announced plans this week to link their insulin pumps with continuous glucose monitors from Abbott. fiercebiotech.com/medtech/abbott…

J&J launches AI surgery funding competition with Nvidia, AWS fiercebiotech.com/medtech/jj-lau…

Pfizer has added another chapter to its long-running drug discovery collaboration with Chinese tech startup XtalPi, this time upgrading their molecular modeling work. fiercebiotech.com/biotech/pfizer…

Catalio Capital Management has closed its fourth venture fund with more than $400 million that will be used in part to launch two new companies. fiercebiotech.com/biotech/catali…

The FDA has cleared its first cuffless blood pressure monitor that will be available over-the-counter, with the Hilo wristband developed by Aktiia. fiercebiotech.com/medtech/fda-cl…

Johns Hopkins’ AI-powered robot performs autonomous surgery fiercebiotech.com/medtech/johns-…

Momentum in Johnson & Johnson’s cardiovascular business continues while the company looks to regain its footing in the burgeoning pulsed field ablation market after stumbles in the launch of its Varipulse system at the top of this year. fiercebiotech.com/medtech/johnso…

Alphabet spinoff SandboxAQ is teaming up with iOncologi to build a new mRNA vaccine for a common and aggressive brain tumor known as glioblastoma. fiercebiotech.com/biotech/alphab…

The highest-paid medtech CEOs fiercebiotech.com/special-report…